Structured evidence table for Collagen Peptides Tendon Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Collagen Peptides Tendon Randomized Trial | Objective To evaluate clinical evidence on oral or injectable hydrolyzed collagen peptides, or related low-molecular-weight peptide preparations, in tendon and ligament injuries and post-repair/reconstruction settings. | 1 | Latini L (2026) | Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. |
| Collagen Peptides Tendon Randomized Trial | Closely related disorders were included only as contextual evidence when direct injury-specific data were limited. | 1 | Latini L (2026) | Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. |
| Collagen Peptides Tendon Randomized Trial | Three provided direct evidence in tear or post-surgical populations: one pilot study of injectable low-molecular-weight peptides in partial supraspinatus tendon tears, one randomized trial after ACL reconstruction, and one randomized trial after rotator cuff repair. | 1 | Latini L (2026) | Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. |
| Collagen Peptides Tendon Randomized Trial | Background Low-molecular-weight hydrolyzed collagen peptides are increasingly used as adjuncts in musculoskeletal medicine, but their clinical role in tendon and ligament injuries remains unclear. | 1 | Latini L (2026) | Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. |
| Collagen Peptides Tendon Randomized Trial | Background Lateral elbow tendinopathy (LET) is a common upper-limb musculoskeletal disorder causing pain during gripping activities, reduced work capacity, and functional limitation. | 4 | Vitale N (2026) | Ultrasound-Guided Collagen Peptides Injections Combined with Focused Extracorporeal Shockwave Therapy and Therapeutic Exercise in Chronic Partial Common Extensor Tendon Tears at Elbow Lateral Epicondyle: A Retrospective Case Series. |
| Collagen Peptides Tendon Randomized Trial | Results PRTEE pain improved by 31.2 points (95% CI 22.2-40.2; Cohen's d_z = 2.48) and PRTEE function by 32.6 points (95% CI 26.7-38.5; d_z = 3.95). | 4 | Vitale N (2026) | Ultrasound-Guided Collagen Peptides Injections Combined with Focused Extracorporeal Shockwave Therapy and Therapeutic Exercise in Chronic Partial Common Extensor Tendon Tears at Elbow Lateral Epicondyle: A Retrospective Case Series. |
| Collagen Peptides Tendon Randomized Trial | Mean maximal strength and maximal strength improved by 4.61 kg (95% CI 2.89-6.32) and 4.02 kg (95% CI 2.36-5.68), respectively. | 4 | Vitale N (2026) | Ultrasound-Guided Collagen Peptides Injections Combined with Focused Extracorporeal Shockwave Therapy and Therapeutic Exercise in Chronic Partial Common Extensor Tendon Tears at Elbow Lateral Epicondyle: A Retrospective Case Series. |
| Collagen Peptides Tendon Randomized Trial | LET is currently considered a predominantly degenerative condition characterized by collagen disorganization, extracellular matrix changes, neovascularization, and impaired tendon healing. | 4 | Vitale N (2026) | Ultrasound-Guided Collagen Peptides Injections Combined with Focused Extracorporeal Shockwave Therapy and Therapeutic Exercise in Chronic Partial Common Extensor Tendon Tears at Elbow Lateral Epicondyle: A Retrospective Case Series. |
Source documents